Clinical studies in Mexico 2025, by phase
As of February 2025, most of the clinical trials carried out in Mexico were registered as being on phase 3 (2,467). Meanwhile, another 17 clinical trials were recorded as in early phase 1. However, from the more than 5,200 clinical studies documented in the country, some were either already completed or no longer active, for different reasons. In 2024, Swiss-based company Roche was expected to be the leader firm among the global top pharmaceutical companies, with some 218 products in its R&D pipeline.
